CIK 0001422143
- Non-accelerated filer
- Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547851
- Phone
- +1 858-500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- Open-market buys, last 90 days
- $4,248,530
- in 3 filings
- Open-market sales, last 90 days
- $1,310,361
- in 7 filings, $252K under 10b5-1 plans
Net +$2,938,169. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- WILSON TROY EDWARD +$4.2M President and CEO 3 filings
- Leoni Mollie −$440K Chief Medical Officer sold 23% of stake
- Powl Brian T. −$397K Chief Commercial Officer sold 21% of stake
- Burrows Francis −$225K Chief Scientific Officer sold 33% of stake
- FORD KATHLEEN −$112K Chief Operating Officer sold 7% of stake
Reading 38 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-10 | WILSON TROY EDWARD President and CEO | Sale | −37,030 | $28.00 | $1.0M | 28,096 |
| 2020-09-10 | WILSON TROY EDWARD President and CEO | Exercise or conversion · Option to purchase common stock | −37,030 | 174,947 | ||
| 2020-09-08 | WILSON TROY EDWARD President and CEO | Sale | −50,000 | $26.00 | $1.3M | 306,736 |
| 2020-09-08 | GRASSO MARC CFO, CBO | Exercise or conversion | +10,000 | $15.47 | $155K | 10,000 |
| 2020-09-08 | GRASSO MARC CFO, CBO | Sale | −10,000 | $26.00 | $260K | 0 |
| 2020-09-08 | GRASSO MARC CFO, CBO | Exercise or conversion · Option to purchase common stock | −10,000 | 112,898 | ||
| 2020-08-25 | WILSON TROY EDWARD President and CEO | Exercise or conversion | +22,838 | $6.15 | $140K | 50,934 |
| 2020-08-25 | WILSON TROY EDWARD President and CEO | Exercise or conversion | +215 | $4.80 | $1K | 51,149 |
| 2020-08-25 | WILSON TROY EDWARD President and CEO | Sale | −23,053 | $22.37 | $516K | 28,096 |
| 2020-08-25 | WILSON TROY EDWARD President and CEO | Exercise or conversion · Option to purchase common stock | −22,838 | 211,977 | ||
| 2020-08-25 | WILSON TROY EDWARD President and CEO | Exercise or conversion · Option to purchase common stock | −215 | 6,945 | ||
| 2020-08-25 | GRASSO MARC CFO, CBO | Exercise or conversion | +10,000 | $15.47 | $155K | 10,000 |
| 2020-08-25 | GRASSO MARC CFO, CBO | Sale | −10,000 | $23.00 | $230K | 0 |
| 2020-08-25 | GRASSO MARC CFO, CBO | Exercise or conversion · Option to purchase common stock | −10,000 | 122,898 | ||
| 2020-08-24 | WILSON TROY EDWARD President and CEO | Exercise or conversion | +6,568 | $4.80 | $32K | 34,664 |
| 2020-08-24 | WILSON TROY EDWARD President and CEO | Sale | −6,568 | $22.04 | $145K | 28,096 |
| 2020-08-24 | WILSON TROY EDWARD President and CEO | Exercise or conversion · Option to purchase common stock | −6,568 | 7,160 | ||
| 2020-08-24 | DALE STEPHEN Chief Medical Officer | Grant or award · Option to purchase common stock | +200,000 | 200,000 | ||
| 2020-08-19 | WILSON TROY EDWARD President and CEO | Exercise or conversion | +11,913 | $4.80 | $57K | 40,009 |
| 2020-08-19 | WILSON TROY EDWARD President and CEO | Sale | −11,913 | $22.09 | $263K | 28,096 |
Page 15 of 19 · 366 trades